Learn more

BIOGEN NV

Overview
  • Total Patents
    350
  • GoodIP Patent Rank
    211,681
  • Filing trend
    ⇩ 50.0%
About

BIOGEN NV has a total of 350 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 1979. It filed its patents most often in Japan, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are BIO TECHNOLOGY GENERAL CORP, THERAPEUTIC ANTIBODIES INC and CALIFORNIA BIOTECHNOLOGY INC.

Patent filings per year

Chart showing BIOGEN NVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Murray Kenneth 39
#2 Schaller Heinz Ernst 25
#3 Weissmann Charles 23
#4 Fiers Walter Charles 20
#5 Movva Nageswararao 12
#6 Fiers Walter C 10
#7 Mackay Patricia 9
#8 Wallner Barbara P 9
#9 Schaller Heinz E 9
#10 Rosa Margaret D 9

Latest patents

Publication Filing date Title
AU1711888A Immunotherapeutic methods and compositions
US4999422A Continuous method of refolding proteins
EP0302925A1 A method for producing factor viii in high yield.
NZ233946A A recombinant dna molecule coding for a modified factor viii:c-like polypeptide
EP0311616A1 Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases
GB8703015D0 Aminopeptidase
WO8703489A1 Combinations of tumor necrosis factors and antibiotics and methods for treating tumors
KE3669A Dna sequences,recombinant dna molecules and processes for producing human interferon-alpha like polypeptides
WO8702060A1 Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
EP0231354A1 Production of a vitamin c precursor using genetically modified organisms.
ES8801383A1 A procedure to purify uromodulin from raw urine
EP0204401A1 Method of improving the yield of polypeptides produced in a host cell by stabilizing mRNA
ZA8509841B Process for purifying tumor necrosis factors and for producing recombinant dna molecules coding for tumor necrosis factor-like compounds and tumor necrosis factors
GB8529014D0 Enhanced secretion of heterologous proteins
IL76460D0 Dna sequences,recombinant dna molecules,processes for producing human interferon-like polypeptides and pharmaceutical and veterinary compositions containing them
GB8522336D0 Composition for treatment of allergies
GB8519536D0 Vitamin c precursor
GB8507833D0 Production of human somatomedin c
WO8504186A2 A modified gamma interferon, dna sequences encoding it and processes for producing it
US4753879A Modified tissue plasminogen activators